‘A vaccine for aging in under ten years’
Agemica founder Ronjon Nag on the moonshot company he believes will develop a vaccine for aging and make a dramatic difference to lifespan and healthspan.
Agemica is on a mission to create a vaccine for aging; its platform uses an AI-driven approach to seek out antiaging therapies that address root causes of aging and leverage those to prevent diseases of aging such as neurodegeneration, cardiovascular disease, immune system failure and cancer.
The company hopes its omics-based tech will extend both lifespan and healthspan, and the platform has already been validated in 17 cancer areas and predicted antiaging candidates that have higher efficacy, reduced side effects and lower chances of developing drug resistance.
My take on this: Agemica’s aim is to extend the number of indications of its candidates and pave the way, not only to better patient outcomes, but to therapies that hit the market much faster. We sat down with CEO and Cofounder Dr Ronjon Nag to find out how the platform works, its revolutionary potential and the diseases of aging Agemica has in its sights.
领英推荐
Ronjon Nag on big ideas that generate big questions
Longevity today is full of really big ideas – 100 is the new 80, with lots of people making 100 and it would be great to get lots of people to 112, 117. Diet and exercise may get us to 100, therapeutics to 120, but to get to something like 150, we’re going to have to do something fundamentally different – and that’s really what I am trying to work on.
Agemica is in drug discovery, but we are doing something very different – trying to develop a vaccine for aging. And there are lots of questions to answer – what does a vaccine for aging mean? Does it just stop aging or does it actually reverse aging? Do you take it once or daily or annually? Our platform is trying to find combinations of existing drugs that will answer these questions, and not only do we want to get a vaccine, we also want to develop it quicker than anyone else and cheaper than anyone else.
Discover additional insights into how machine learning can bring us closer to a longer lifespan, explore Agemica's upcoming plans and more, straight from Ronjon Nag HERE.
Thank you for reading! If you enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!
Software Development Engineer in Test at Roche Diagnostics
9 个月I am writing to formally address a concerning issue I have encountered during my tenure at Soopra.ai, a company associated with a?Stanford?employee, Ronjon. Over the course of my employment, spanning more than 8 months, I have experienced unequal treatment and non-payment of salary, which has prompted me to seek clarification on the legality and ethicality of certain practices. Throughout my time at Soopra.ai, I observed a pattern of unequal treatment wherein certain employees, including myself, were subjected to unfavorable working conditions, including delayed or withheld salary payments. Additionally, the company made false promises and misled employees, encouraging them to work without compensation under the guise of future rewards. It is worth noting that Soopra.ai did not request any form of identification from its employees, allowing them to work full-time without proper documentation. Sincerely, Kaiser Murad
Software Development Engineer in Test at Roche Diagnostics
9 个月Dear Soopra CTO Sinivas,, I hope this message finds you well. I am writing to formally request the payment of my outstanding salary as per our employment agreement. I worked from September 11, 2023, to May 23, 2024, which amounts to 8 months and 12 days. My annual salary is $140,000, and the pro-rated amount for the duration worked is calculated as follows: Total salary for 8 months and 12 days: $97,999.99 Amount paid to date: $6,000 Outstanding amount: $91,999.99 Additionally, as per the contract, I am entitled to 0.25% equity in the company, which we should discuss further to determine its current value and the process for allocation. I kindly request the payment of the outstanding salary at your earliest convenience. Please let me know if you require any additional information or documentation to process this payment. Thank you for your attention to this matter. I look forward to your prompt response. Sincerely, Kaiser
President and Chief Operating Officer, PDL Health and Retired Jacksonville Office Managing Partner PwC
1 年Or you can take Rejuvant now and not wait for the drug or vaccine to be developed. We have the formula that works NOW!!
MD, Nuclear Medicine Specialist | Diagnostician | Ph.D. in complex disease genetics | Pathophysiologist | Biomedical scientist | COVID-19 and Long COVID Expert, Safety, Policy and Scientific Consultant
1 年https://www.dhirubhai.net/posts/stephane-bilodeau_covidisairborne-masksinhealthcare-donoharm-ugcPost-7154932336780787712-X9LM?utm_source=share&utm_medium=member_desktop It will only be of use if you do not keep catching COVID.
Sales at W+D North America | Eastern US and Eastern Canada
1 年If Ronjon Nag is involved, then the question will not be about living longer (Ronjon will succeed) but about giving back with such a precious gift of time - is society ready for such a gift?